According to The White House (@WhiteHouse), Gilead Sciences has announced an $11 billion investment to expand domestic manufacturing and research in the United States. This significant capital injection is expected to increase biotech sector activity, potentially boosting investor confidence in U.S. innovation. For traders, heightened optimism in traditional equities often drives ancillary interest in digital assets, especially as institutional capital flows diversify. The announcement may serve as a bullish signal for cryptocurrency markets tied to U.S. economic growth and technological advancement, as noted by the official White House Twitter account (source: https://twitter.com/WhiteHouse/status/1920662215025115383).